FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 58 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,731,360 | -48.5% | 283,365 | -6.3% | 0.06% | -53.1% |
| Q1 2024 | $3,363,555 | +6.1% | 302,478 | +7.1% | 0.13% | -24.4% |
| Q4 2023 | $3,169,403 | +47.6% | 282,478 | -1.2% | 0.17% | +41.0% |
| Q3 2023 | $2,147,800 | -14.2% | 285,992 | +0.9% | 0.12% | -37.1% |
| Q2 2023 | $2,502,537 | +19.2% | 283,413 | +12.3% | 0.19% | -1.5% |
| Q1 2023 | $2,099,020 | +42.8% | 252,286 | +64.8% | 0.20% | +51.5% |
| Q4 2022 | $1,469,472 | – | 153,070 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,056,000 | 0.85% |
| Southpoint Capital Advisors LP | 3,997,214 | $19,386,000 | 0.82% |
| 683 Capital Management, LLC | 971,351 | $4,711,000 | 0.43% |
| Avoro Capital Advisors LLC | 1,105,999 | $5,364,000 | 0.23% |
| Eventide Asset Management | 720,000 | $3,492,000 | 0.12% |
| Granahan Investment Management | 410,932 | $1,993,000 | 0.11% |
| Zebra Capital Management LLC | 17,568 | $85,000 | 0.04% |
| Hartford Financial Management Inc. | 12,300 | $60,000 | 0.02% |
| OXFORD ASSET MANAGEMENT LLP | 84,750 | $411,000 | 0.01% |
| Wealthspire Advisors, L.P. | 9,500 | $46,000 | 0.00% |